Switch to:
Allergan Inc (NYSE:AGN)
Cash Flow from Operations
$1,928 Mil (TTM As of Dec. 2014)

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2014, Allergan Inc's Net Income From Continuing Operations was $539 Mil. Its DDA was $63 Mil. Its Change In Working Capital was $52 Mil. Its cash flow from deferred tax was $-66 Mil. Its Cash Flow from Discontinued Operations was $0 Mil. Its Stock Based Compensation was $53 Mil. And its Cash Flow from Others was $54 Mil. In all, Allergan Inc's Cash Flow from Operations for the three months ended in Dec. 2014 was $694 Mil.


Definition

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Allergan Inc's Cash Flow from Operations for the fiscal year that ended in Dec. 2014 is calculated as:

Allergan Inc's Cash Flow from Operations for the quarter that ended in Dec. 2014 is

Allergan Inc Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2014 was 165.8 (Mar. 2014 ) + 473.3 (Jun. 2014 ) + 594.5 (Sep. 2014 ) + 694.2 (Dec. 2014 ) = $1,928 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Allergan Inc's net income from continuing operations for the three months ended in Dec. 2014 was $539 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
• The term “depreciation” is used when discussing man made tangible assets
• The term “depletion” is used when discussing natural tangible assets
• The term “amortization” is used when discussing intangible assets

Allergan Inc's depreciation, depletion and amortization for the three months ended in Dec. 2014 was $63 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Allergan Inc's change in working capital for the three months ended in Dec. 2014 was $52 Mil. It means Allergan Inc's working capital increased by $52 Mil from Sep. 2014 to Dec. 2014 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Allergan Inc's cash flow from deferred tax for the three months ended in Dec. 2014 was $-66 Mil.

5. Cash Flow from Discontinued Operations:
Cash received by a company that comes from the sale of part of business.

Allergan Inc's cash flow from discontinued operations for the three months ended in Dec. 2014 was $0 Mil.

6. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Allergan Inc's stock based compensation for the three months ended in Dec. 2014 was $53 Mil.

7. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Allergan Inc's cash flow from others for the three months ended in Dec. 2014 was $54 Mil.


Related Terms

Net Income From Continuing Operations, Depreciation, Depletion and Amortization, Change In Working Capital, Cash Flow from Discontinued Operations, Stock Based Compensation, Cash Flow from Others, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
NetIncomeFromContinuingOperations 404-12749956562459381,1039891,529
CF_DDA 89162219264262257253257255248
ChangeInWorkingCapital -9785-33-205113-68-16317147-193
CF_DeferredTax -25-48-82-101-113-249-69-88-192-80
Cash Flow from Disc. Op. 0000000000
Stock Based Compensation 000931527486109114160
Cash Flow from Others 5467618966754453649483264
Cash Flow from Operations 4257477936831,1134641,0821,6001,6951,928

Allergan Inc Quarterly Data

Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14
NetIncomeFromContinuingOperations 25132514361301312258418313539
CF_DDA 65657361616061606463
ChangeInWorkingCapital 133117-2645915498-227-381952
CF_DeferredTax -28-480-101-33-5804-17-66
Cash Flow from Disc. Op. 0000000000
Stock Based Compensation 27292928283035314153
Cash Flow from Others 151126773687439-317554
Cash Flow from Operations 462500120482579515166473595694
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK